Literature DB >> 16728643

Pituitary adenoma predisposition caused by germline mutations in the AIP gene.

Outi Vierimaa1, Marianthi Georgitsi, Rainer Lehtonen, Pia Vahteristo, Antti Kokko, Anniina Raitila, Karoliina Tuppurainen, Tapani M L Ebeling, Pasi I Salmela, Ralf Paschke, Sadi Gündogdu, Ernesto De Menis, Markus J Mäkinen, Virpi Launonen, Auli Karhu, Lauri A Aaltonen.   

Abstract

Pituitary adenomas are common in the general population, and understanding their molecular basis is of great interest. Combining chip-based technologies with genealogy data, we identified germline mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene in individuals with pituitary adenoma predisposition (PAP). AIP acts in cytoplasmic retention of the latent form of the aryl hydrocarbon receptor and also has other functions. In a population-based series from Northern Finland, two AIP mutations account for 16% of all patients diagnosed with pituitary adenomas secreting growth hormone and for 40% of the subset of patients who were diagnosed when they were younger than 35 years of age. Typically, PAP patients do not display a strong family history of pituitary adenoma; thus, AIP is an example of a low-penetrance tumor susceptibility gene.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16728643     DOI: 10.1126/science.1126100

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  167 in total

Review 1.  PRKAR1A and the evolution of pituitary tumors.

Authors:  Lawrence S Kirschner
Journal:  Mol Cell Endocrinol       Date:  2010-05-06       Impact factor: 4.102

Review 2.  Familial pediatric endocrine tumors.

Authors:  Sarinda Millar; Lisa Bradley; Deirdre E Donnelly; Dennis Carson; Patrick J Morrison
Journal:  Oncologist       Date:  2011-09-20

3.  Concomitant deletions of tumor suppressor genes MEN1 and AIP are essential for the pathogenesis of the brown fat tumor hibernoma.

Authors:  Karolin H Nord; Linda Magnusson; Margareth Isaksson; Jenny Nilsson; Henrik Lilljebjörn; Henryk A Domanski; Lars-Gunnar Kindblom; Nils Mandahl; Fredrik Mertens
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-15       Impact factor: 11.205

4.  The role of germline AIP, MEN1, PRKAR1A, CDKN1B and CDKN2C mutations in causing pituitary adenomas in a large cohort of children, adolescents, and patients with genetic syndromes.

Authors:  C A Stratakis; M A Tichomirowa; S Boikos; M F Azevedo; M Lodish; M Martari; S Verma; A F Daly; M Raygada; M F Keil; J Papademetriou; L Drori-Herishanu; A Horvath; K M Tsang; M Nesterova; S Franklin; J-F Vanbellinghen; V Bours; R Salvatori; A Beckers
Journal:  Clin Genet       Date:  2010-11       Impact factor: 4.438

Review 5.  Genomic Alterations in Sporadic Pituitary Tumors.

Authors:  Wenya Linda Bi; Alexandra Giantini Larsen; Ian F Dunn
Journal:  Curr Neurol Neurosci Rep       Date:  2018-02-02       Impact factor: 5.081

6.  Familial pituitary adenomas with a heterogeneous functional pattern: clinical and genetic features.

Authors:  G Raverot; W Arnous; A Calender; J Trouillas; G Sassolas; C Bournaud; M Pugeat; F Borson-Chazot
Journal:  J Endocrinol Invest       Date:  2007-10       Impact factor: 4.256

Review 7.  Genetics of Cushing's Syndrome.

Authors:  Laura C Hernández-Ramírez; Constantine A Stratakis
Journal:  Endocrinol Metab Clin North Am       Date:  2018-06       Impact factor: 4.741

8.  Interaction of AIP with protein kinase A (cAMP-dependent protein kinase).

Authors:  Marie Helene Schernthaner-Reiter; Giampaolo Trivellin; Constantine A Stratakis
Journal:  Hum Mol Genet       Date:  2018-08-01       Impact factor: 6.150

9.  Where is the culprit? A case of acromegaly that defied the management algorithm.

Authors:  Celito A Tamban; Mark Anthony S Sandoval; Frances Lina Lantion-Ang
Journal:  BMJ Case Rep       Date:  2013-01-17

10.  Aryl Hydrocarbon Receptor Interacting Protein Targets IRF7 to Suppress Antiviral Signaling and the Induction of Type I Interferon.

Authors:  Qinjie Zhou; Alfonso Lavorgna; Melissa Bowman; John Hiscott; Edward W Harhaj
Journal:  J Biol Chem       Date:  2015-04-24       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.